Mode
Text Size
Log in / Sign up
Phase 3 N=16 Randomized Treatment

Physiologic Comparison Between NIV-NAVA and PS in Preterm Infants

Noninvasive Neurally Adjusted Ventilatory Assist and Pressure Support in Preterm Infants

Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Dec 2015
Primary outcome: Primary: Trigger Delay — 35.2; 294.6 ms — p=<0.001

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
noninvasive respiratory support with NAVA mode and PSV (Device)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Seoul National University Hospital
Primary completion
Apr 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Trigger Delay
35.2; 294.6 <0.001 sig
SECONDARY
Ti_excess (Inspiratory Time in Excess)
32.2; 56.8 0.001 sig
SECONDARY
Minute Ventilation Volume
114.9; 124.1 0.74
SECONDARY
Peak Inspiratory Pressure
12.3; 14.7 0.003 sig
SECONDARY
Pneumatic Respiratory Rate
46.3; 33.3 0.002 sig
SECONDARY
Maximum EAdi
12.6; 16.6 0.003 sig
SECONDARY
Swing EAdi
8.8; 12.2 0.012 sig
SECONDARY
Leakage
87.6; 86.7 0.67
SECONDARY
All Asynchrony Events
8.2; 47.6 <0.001 sig
SECONDARY
Asynchrony Index
19.7; 73.9 <0.001 sig
SECONDARY
SpO2
SECONDARY
Heart Rate
SECONDARY
Blood Pressure
SECONDARY
Respiratory Rate

Summary

Neurally adjusted ventilatory assist (NAVA) has been shown to improve patient- ventilator interaction and reduce asynchronies. This is a short-term physiologic comparison between PSV (pressure support ventilation) and NAVA in delivering noninvasive ventilation through a nasal cannula, in premature infants postextubation. Patients will undergo a 30-min crossover trial of noninvasive PSV and NAVA, 15 minutes each. Diaphragm electrical activity (EAdi)and airway pressure (Paw) are recorded to derive neural and mechanical respiratory rate and timing, inspiratory trigger delays time of synchrony between diaphragm contraction and ventilator assistance, and the asynchrony index (AI).

Eligibility Criteria

Inclusion Criteria

  • preterm infants less than 32 weeks of gestational age
  • intubated more than 48 hours after birth
  • subjected to extubation with minimal ventilator setting (mean airway pressure < 7cmH2O + peak inspiratory pressure < 13 cmH2O + FiO2 < 0.4 + respiratory rate < 35/min)
  • with informed consent from parents

Exclusion Criteria

  • with major congenital anomalies
  • use of sedative or anesthetic drugs
  • hemodynamic instability
  • grade 3 or higher intraventricular hemorrhage
  • phrenic nerve palsy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01877720). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search